About this trial
This single-center, prospective, observational study compares target-controlled infusion (TCI) versus manually administered total intravenous anesthesia (TIVA) for sedation in patients undergoing kyphoplasty in the prone position. The primary endpoints are the incidence of hypoxic episodes (SpO₂ \< 90%) and apneic attacks. Secondary endpoints include anesthesia quality scores, integrated pulmonary index (IPI) values, total propofol consumption, time to eye opening, time to full orientation, Modified Aldrete Scores and Richmond Agitation-Sedation Scale (RASS) scores in the recovery unit, and patient and surgeon satisfaction.
Eligibility criteria
Qualifiers
ASA physical status classification I-III
Scheduled for kyphoplasty under sedation in the prone position
Provision of written informed consent
Disqualifiers
Known allergy to any of the study medications
ASA physical status classification IV or higher
Patients deemed unsuitable for sedation (high pulmonary risk, morbid obesity, diagnosed severe obstructive sleep apnea)
Refusal to participate or withdrawal of consent
Trial design
Treatments tested in this trial
- Target controlled infusion of propofol
- non invasive ETCO2 monitoring